First hybrid implantations of novel Salus-Valves in patients with severe pulmonary regurgitation: A case series

Zehua Shao; Shubo Song; Yu Han; Weijie Liang; Taibing Fan

doi:10.3389/fcvm.2022.1059664

First hybrid implantations of novel Salus-Valves in patients with severe pulmonary regurgitation: A case series

Front Cardiovasc Med. 2022 Nov 24:9:1059664. doi: 10.3389/fcvm.2022.1059664. eCollection 2022.

Authors

Zehua Shao¹, Shubo Song¹, Yu Han², Weijie Liang¹, Taibing Fan¹

Affiliations

¹ Children's Heart Center, Zhengzhou University People's Hospital, Fuwai Central China Cardiovascular Hospital, Henan Provincial People's Hospital, Zhengzhou, China.
² Department of Structural Cardiology, Zhengzhou University People's Hospital, Fuwai Central China Cardiovascular Hospital, Henan Provincial People's Hospital, Zhengzhou, China.

Abstract

With the increasing age of patients after right ventricular outflow tract (RVOT) reconstruction, progressive pulmonary valve (PV) dysfunction can result in different degrees of right heart insufficiency, and PV replacement is frequently needed during follow-up. The traditional redo thoracotomy is difficult and associated with higher risks when compared to transcatheter implantations. Herein, we report the advantages and describe the outcomes of the first hybrid implantations of the novel Salus-Valves (Balance Medical, Beijing, China) from the sub-xiphoid approach in five patients (mean age of 22.6 years) with severe pulmonary regurgitation (PR) after RVOT reconstruction.

Keywords: invasive surgical procedures; pulmonary regurgitation; right ventricular outflow tract (RVOT); transcatheter pulmonary valve implantation; valve implantation.

Publication types

Case Reports